NORMAN W BARTON, MD
Neurology at Overshot Ct, Phoenix, MD
License number
Maryland D0026536
Category
Neurology
Type
Neurology
Address
Address
19 Overshot Ct, Phoenix, MD 21131
Phone
(410) 667-4298
(410) 667-8429 (Fax)
(410) 667-8429 (Fax)
Organization information
See more information about NORMAN W BARTON at bizstanding.comNorman W Barton MD
19 Overshot Ct, Phoenix, MD 21131
Categories:
Internal Medicine Physicians & Surgeons
Phone:
(410) 667-8429 (Phone)
Professional information
Dr. Norman W Barton, Phoenix MD - MD (Doctor of Medicine)
Specialties:
Neuropsychiatry (Neurology)
Address:
19 Overshot Ct, Phoenix 21131
(410) 667-4298 (Phone), (410) 667-8429 (Fax)
(410) 667-4298 (Phone), (410) 667-8429 (Fax)
Certifications:
Neurology, 1984
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Pennsylvania State University / College of Medicine
Graduated: 1976
Albany Memorial Hospital
Cornell-Ny Hosp
Nih Bethesda
Pennsylvania State University / College of Medicine
Graduated: 1976
Albany Memorial Hospital
Cornell-Ny Hosp
Nih Bethesda
Compositions, And Kits Comprising Targeted Aldehyde Or Acetal Protease Inhibitor Compounds For Treating Muscle Disorders
US Patent:
2008003, Feb 14, 2008
Filed:
Dec 28, 2005
Appl. No.:
11/321782
Inventors:
Alfred Stracher - Roslyn NY, US
Leo Kesner - West Orange NJ, US
Ted Carver - Charlotte NC, US
Norman Barton - Phoenix MD, US
Leo Kesner - West Orange NJ, US
Ted Carver - Charlotte NC, US
Norman Barton - Phoenix MD, US
International Classification:
A61K 31/11, A61P 21/00
US Classification:
514693000
Abstract:
Described herein are compounds that comprise a carrier residue that is or is an analog of carnitine, an optional linker group, and a residue of a protease inhibitor comprising an aldehyde group or acetal derivatives of the aldehyde group, and pharmaceutical compositions and kits thereof. The compounds, compositions, and kits are useful for treating muscle disorders in animals and humans that result from the undesired activity of biological proteases. The compounds of the invention are particularly effective as calpain inhibitors, and can be used to treat the resulting muscular disorders, exemplified by Duchenne or Becker muscular dystrophy.
Compounds For Treating Neurologic Diseases, Otologic Diseases, Or Ophthalmologic Diseases And Methods Of Use Thereof
US Patent:
2008020, Aug 21, 2008
Filed:
Sep 29, 2005
Appl. No.:
11/663666
Inventors:
Alfred Stracher - Roslyn NY, US
Leo Kesner - West Orange NJ, US
Ted Carver - Charlotte NC, US
Norman W. Barton - Phoenix MD, US
Leo Kesner - West Orange NJ, US
Ted Carver - Charlotte NC, US
Norman W. Barton - Phoenix MD, US
International Classification:
A61K 38/06, A61K 38/05, A61P 25/00, A61P 27/02
US Classification:
514 18, 514 19
Abstract:
Described herein are compounds and methods for treating or preventing a neurologie, otologic, or ophthalmologic disease in a subject. Also described herein are compounds that can be used as therapeutics.
Treatment Of Traumatic Or Degenerative Neurologic, Otologic, Or Ophthalmologic Diseases With Targeted Protease Inhibitors
US Patent:
2012013, May 31, 2012
Filed:
Jun 27, 2011
Appl. No.:
13/170053
Inventors:
Alfred Stracher - Roslyn NY, US
Leo Kesner - West Orange NJ, US
Ted Carver - Charlotte NC, US
Norman W. Barton - Phoenix MD, US
Leo Kesner - West Orange NJ, US
Ted Carver - Charlotte NC, US
Norman W. Barton - Phoenix MD, US
International Classification:
A61K 38/06, A61P 25/00
US Classification:
514 13, 514 177
Abstract:
Described herein are compounds and methods for treating or preventing a neurologic, otologic, or ophthalmologic disease in a subject. Also described herein are compounds that can be used as therapeutics.